Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set
Authors
Keywords
Melanoma, Lung cancer, Total mutation load, CTLA-4, PD-1, Immunotherapy
Journal
BMC Medicine
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-10-24
DOI
10.1186/s12916-016-0705-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- Clinical Actionability Enhanced through Deep Targeted Sequencing of Solid Tumors
- (2015) K. Chen et al. CLINICAL CHEMISTRY
- A scaling aneurysm model-based approach to assessing the role of flow pattern and energy loss in aneurysm rupture prediction
- (2015) Yunling Long et al. Journal of Translational Medicine
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
- (2015) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
- (2014) Carsten Linnemann et al. NATURE MEDICINE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- High sensitivity of cancer exome-based CD8 T cell neo-antigen identification
- (2014) Marit M van Buuren et al. OncoImmunology
- Exomics and immunogenics
- (2014) Stéphane Champiat et al. OncoImmunology
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer
- (2013) Charles G. Drake et al. Nature Reviews Clinical Oncology
- Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumors
- (2013) Willem W Overwijk et al. Journal for ImmunoTherapy of Cancer
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
- (2012) Marcin Imielinski et al. CELL
- New Strategies in Melanoma: Molecular Testing in Advanced Disease
- (2012) Scott E. Woodman et al. CLINICAL CANCER RESEARCH
- Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
- (2012) Michael Krauthammer et al. NATURE GENETICS
- Advances in the development of cancer immunotherapies
- (2012) Jianjun Gao et al. TRENDS IN IMMUNOLOGY
- Final Version of 2009 AJCC Melanoma Staging and Classification
- (2009) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started